Home » Wyeth Gets Subpoena for Protonix Pricing
Wyeth Gets Subpoena for Protonix Pricing
March 14, 2005
Wyeth Pharmaceuticals said it was served with a subpoena from the U.S. Attorney's Office in Massachusetts over pricing practices for its Protonix heartburn drug. The subpoena seeks documents from January 2000 to the present relating to the company's quarterly calculations of the "average manufacturer price," or AMP, and "best price" for Protonix oral tablets and intravenous products, according to Wyeth's annual report filed Monday with the Securities and Exchange Commission.
Yahoo News (http://news.yahoo.com/news?tmpl=story&u=/ap/20050314/ap_on_bi_ge/wyeth_subpoena_2)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct